Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Clear Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04981119
What this trial is testing

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Who this might be right for
Solid Tumor, AdultColorectal CancerNon Small Cell Lung Cancer+14 more
A2 Biotherapeutics Inc. 500
Not applicableLooking for participantsNCT07485114
What this trial is testing

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Non Small Cell Lung CancerHepatocellular Carcinoma+1 more
Daniel Keizman 300
Not applicableStudy completedNCT05363072
What this trial is testing

Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Who this might be right for
Renal Cell CancerRenal Cell CarcinomaCancer of Kidney+4 more
Pfizer 1,112
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Early research (Phase 1)Ended earlyNCT02650635
What this trial is testing

TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Breast Carcinoma+14 more
Mayo Clinic 4
Early research (Phase 1)Not Yet RecruitingNCT05698238
What this trial is testing

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more
Mabpro, a.s. 50
Not applicableStudy completedNCT00310115
What this trial is testing

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
M.D. Anderson Cancer Center 469
Large-scale testing (Phase 3)Study completedNCT00478114
What this trial is testing

Efficacy and Safety of Sorafenib in Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell Carcinoma
Mahidol University 15
Not applicableActive Not RecruitingNCT04106349
What this trial is testing

Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Advanced or Metastatic Renal Cell Carcinoma
Ipsen 150
Testing effectiveness (Phase 2)UnknownNCT06129955
What this trial is testing

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)UnknownNCT00093522
What this trial is testing

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

Who this might be right for
Kidney Cancer
St. Luke's Medical Center 28
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more
GI Innovation, Inc. 317
Early research (Phase 1)Active Not RecruitingNCT05789069
What this trial is testing

HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

Who this might be right for
Renal Cell CarcinomaMelanomaNon Small Cell Lung Cancer+2 more
HiFiBiO Therapeutics 83
Early research (Phase 1)Study completedNCT01638533
What this trial is testing

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00635791
What this trial is testing

Phase I Study of Vorinostat and Sorafenib in Advanced Cancer

Who this might be right for
Malignant Solid TumourRenal Cell CarcinomaNon Small Cell Lung Carcinoma
University of Colorado, Denver 36
Early research (Phase 1)Looking for participantsNCT06792552
What this trial is testing

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsPlatinum Resistant Ovarian CancerFallopian Tube Cancer+5 more
NextCure, Inc. 738
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableEnrolling By InvitationNCT06885424
What this trial is testing

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

Who this might be right for
Solid Tumor CancerSolid Tumor, Unspecified, AdultColorectal Carcinoma+12 more
A2 Biotherapeutics Inc. 400
Early research (Phase 1)Study completedNCT03236935
What this trial is testing

Phase Ib of L-NMMA and Pembrolizumab

Who this might be right for
Non-Small Cell Lung CancerMalignant MelanomaHead and Neck Squamous Cell Carcinoma+3 more
The Methodist Hospital Research Institute 12
Early research (Phase 1)Study completedNCT01727076
What this trial is testing

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more
National Cancer Institute (NCI) 20
Next Page